Get Unlimited Plan at 75% OFF!

Advertisement
logo

GPT Healthcare

GPTHEALTH
Small Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement

GPT Healthcare Share price and Fundamental Analysis

View All Details
View All Details
GPT Healthcare Limited was formerly established as 'Jibansatya Printing House Private Limited' on August 17, 1989 at Kolkata, West Bengal. The name of Company was changed to 'GPT Healthcare Private Limited' by the Registrar of Companies on March 31, 2005. Thereafter, Company converted to a Public Company and the name was changed to 'GPT Healthcare Limited'. Consequent upon change in name to a Limited Company, a fresh Certificate of Incorporation was issued by the RoC on September 15, 2021.
Company Incorporation1989
ChairmanNA
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
1,217.69
PE Ratio
24.45
Industry P/E
63.46
PEG Ratio
0
ROE
21.25%
ROCE
27.66%
ROA
14.38%
Total Debt (Cr)
27.89
Debt to Equity
0.12
Dividend Yield
2.36%
EPS
6.07
Book Value & P/B
28.15 x 5.27
Face Value
10
Outstanding Shares(Cr)
8.21
Current Ratio
1.3
EV to Sales
3.06

Included In

+More

Stock Returns

1 Week-3.96%
1 Month-11.09%
6 Months-15.01%
1 Year-6.46%
3 Years-26.08%
5 Years-26.08%

CAGR

1 Year CAGR

Revenue Growth

+38.99%

Net Profit Growth

+97.51%

Operating Profit Growth

+43.05%

Dividend Growth

-100%

Stock Returns CAGR

-6.46%
no_data

No Stocks

Smart Score

2
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
Mar 25

Promoters : 65.57%

FIIs : 4.48%

DIIs : 11.35%

Public : 18.59%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr
DII Shareholding Increased by 0.05% to 11.35% in March 2025 Qtr
FII Shareholding Decreased by 0.23% to 4.48% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

GPT Healthcare Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

GPT Healthcare Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

GPT Healthcare Limited was formerly established as 'Jibansatya Printing House Private Limited' on August 17, 1989 at Kolkata, West Bengal. The name of Company was changed to 'GPT Healthcare Private Limited' by the Registrar of Companies on March 31, 2005. Thereafter, Company converted to a Public Company and the name was changed to 'GPT Healthcare Limited'. Consequent upon change in name to a Limited Company, a fresh Certificate of Incorporation was issued by the RoC on September 15, 2021.

The Company is one of the leading regional corporate healthcare companies in Eastern India in terms of number of beds and hospitals. It operate a chain of mid-sized hospitals under the 'ILS Hospitals' brand and provide integrated healthcare services, focusing on secondary and tertiary care. It operate and manage a network of four multi-specialty hospitals, with a total capacity of 556 beds. It offer a comprehensive range of healthcare services across over 35 specialties and super specialties including internal medicine and diabetology, nephrology, laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics and neonatology. Each of their hospitals provides integrated diagnostic services and pharmacies catering to patients. Apart from these, it also provide outpatient services, including consultation for a range of ailments and preventive health screenings.

Led by the Promoter, Dr. Om Tantia, the first hospital was started in Salt Lake, West Bengal in year 2000, with a capacity of eight beds, which has grown to 85 beds, including 17 beds across various ICUs and HDUs. However, in 2005 the Company purchased a small nursing home consisting of operating theatre, labour room and nursery, diagnostic services, dental clinic and diabetic clinic facilities from Tantia Medical Services Private Limited on a going concern basis for a consideration of Rs 33 million.

Later, the Company commissioned a second hospital in Agartala, Tripura in the year 2011 as a multi-specialty tertiary care centre with a capacity of 205 beds with a Nursing School. It established hospital in Dum Dum Kolkata in year, 2013 having a capacity of 150 beds and was authorized to perform renal transplant services.

In 2019, it commissioned a tertiary care hospital in Howrah with a capacity of 116 beds and in 2021, has started B.Sc degrees in Nursing training 50 students in every batch from September, 2021.

The Company is planning to come out with an initial public offer by raising capital through fresh issue of Rs. 17.5 crore and an offer for sale by issuing 29,887,486 Equity Shares.

GPT Healthcare Share Price

GPT Healthcare share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

GPT Healthcare Market Cap

Market capitalization of GPT Healthcare indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how GPT Healthcare is valued compared to its competitors.

GPT Healthcare PE Ratio

GPT Healthcare PE ratio helps investors understand what is the market value of each stock compared to GPT Healthcare 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

GPT Healthcare PEG Ratio

The PEG ratio of GPT Healthcare evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

GPT Healthcare ROE (Return on Equity)

Return on Equity (ROE) measures how effectively GPT Healthcare generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

GPT Healthcare ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of GPT Healthcare in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

GPT Healthcare Total Debt

Total debt of GPT Healthcare shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

GPT Healthcare Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of GPT Healthcare compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

GPT Healthcare CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of GPT Healthcare over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

GPT Healthcare Technical Analysis

Technical analysis of GPT Healthcare helps investors get an insight into when they can enter or exit the stock. Key components of GPT Healthcare Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where GPT Healthcare shares often struggle to rise above due to selling pressure.

GPT Healthcare Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect GPT Healthcare ’s financial health and profitability.

GPT Healthcare Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

GPT Healthcare Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

GPT Healthcare Financials

The financials of GPT Healthcare provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

GPT Healthcare Profit and Loss Statements

The profit and loss statement of GPT Healthcare highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of GPT Healthcare .

GPT Healthcare Balance Sheet

The balance sheet presents a snapshot of GPT Healthcare ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

GPT Healthcare Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App